C4 TherapeuticsvsUnitedHealth

CCCC and UNH stock compared: price, dividend, valuation and results, from SEC filings.

CCCC

C4 Therapeutics, Inc.

$2.53

Value $332M

-4.53%
CCCC's page

UNH

UnitedHealth Group Incorporated

$389.68

Value $354B

-5.42%
UNH's page

C4 Therapeutics (CCCC) has a market value of $332M and UnitedHealth (UNH) $354B. Over the last year, with dividends, CCCC moved +2.4% and UNH +24.3%. Dividend yield: CCCC none, UNH 2.32%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CCCC$332M

    UNH$354B

    UNH is 1,065 times CCCC

  • Revenue, 12 months

    CCCC$32M

    UNH$450B

    UNH is 13,931 times CCCC

  • Net income, 12 months

    CCCC-$91M

    UNH$15.9B

  • Operating margin

    CCCC-315.9%

    UNH5.3%

    321.2 points apart

  • ROIC

    CCCC-35.9%

    UNH11.3%

    47.2 points apart

  • P/E

    CCCC–

    UNH22.3

  • Dividend yield

    CCCC0.0%

    UNH2.3%

    2.3 points apart

  • 5-year return

    CCCC-93.8%

    UNH-5.1%

    88.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CCCC-93.8%

UNH-5.1%

05010020222023202420252026
Returns by period
PeriodCCCCWith dividendsUNHWith dividends
1 year since November 14, 2025+2.4%Price +2.4%+24.3%Price +21.1%
3 years since November 17, 2023+39.8%+11.8% a yearPrice +39.8%-22.6%-8.2% a yearPrice -27.3%
5 years since November 16, 2021-93.8%-42.7% a yearPrice -93.8%-5.1%-1.0% a yearPrice -13.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CCCCC4 TherapeuticsUNHUnitedHealth

Valuation

CCCCUNH
Valuation
Price$2.53$389.68
Market value$332M$354B
Enterprise value (EV)$58M$399B
P/E–22.3
P/E, 5-year median–25.0
P/B1.53.4
EV/EBIT–16.7
Free cash flow yield–6.5%

Results and growth

CCCCUNH
Results and growth
Revenue, 12 months$32M$450B
Net income, 12 months-$91M$15.9B
Free cash flow, 12 months-$80M$22.8B
Earnings per share, 12 months-$0.63$17.52
Revenue growth, year on year1.0%11.8%
Revenue growth a year, past-5.9%over 4 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

CCCCUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin-315.9%5.3%
Net margin-282.2%3.5%
ROIC-35.9%11.3%
ROE-40.6%15.5%

Balance sheet

CCCCUNH
Balance sheet
Cash$275M$28.5B
Total debt$55M$74.3B
Net debt / EBITDA–1.6
Interest cover–6.2×

Dividends and buybacks

CCCCUNH
Dividends and buybacks
Dividend yield–2.3%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield0.1%1.6%
Shareholder yield0.1%3.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CCCC or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, C4 Therapeutics or UnitedHealth?

By market value, UnitedHealth ($354B) is about 1,064.6 times C4 Therapeutics ($332M), at today's prices.

How did CCCC and UNH stock do over the last 5 years?

Since November 16, 2021, CCCC's price moved -93.8% and UNH's -13.3%. With dividends: CCCC -93.8% (-42.7% a year), UNH -5.1% (-1.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, CCCC or UNH?

The dividend yield at today's price is none for C4 Therapeutics and 2.32% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, C4 Therapeutics or UnitedHealth?

Over the last twelve months, the net margin was -282.2% for C4 Therapeutics and 3.5% for UnitedHealth, and the operating margin -315.9% and 5.3%. Revenue was $32M and $450B.

Which is the better investment, C4 Therapeutics or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.